EVEREST ORGANICS LTD.

Everest Organics Ltd has announced its 33rd Annual Report for FY 2025-26, marking a significant financial turnaround. The company reported a total revenue of ₹19,740.42 Lakhs, a 23% increase from the previous year's ₹16,016.59 Lakhs. Profit Before Tax (PBT) turned positive at ₹804.67 Lakhs, reversing a loss of ₹324.26 Lakhs in FY 2024-25. Net Profit for FY26 stood at ₹554.65 Lakhs, compared to a Net Loss of ₹129.03 Lakhs in the prior year, with Earnings Per Share (EPS) at ₹5.70. The company has not recommended a dividend, opting to reinvest earnings to strengthen reserves and surplus to ₹6,576.77 Lakhs. Everest Organics is also investing in expanding its manufacturing capacity for APIs and Intermediates, securing an Environmental Clearance Certificate and pursuing further approvals. The 33rd Annual General Meeting (AGM) is scheduled for September 30, 2026, with e-voting available from September 27-29, 2026.

Everest Organics Ltd has announced its 33rd Annual General Meeting (AGM) scheduled for September 30, 2026, to be held via Video Conferencing. The company has also released its Annual Report for FY 2025-26, highlighting a significant financial turnaround. Total revenue increased by over 23% to ₹19,740.42 Lakhs. Profit Before Tax (PBT) reversed from a loss of ₹324.26 Lakhs in FY 2024-25 to a profit of ₹804.67 Lakhs in FY 2025-26. Net Profit stood at ₹554.65 Lakhs, compared to a Net Loss of ₹129.03 Lakhs in the previous year, with Earnings Per Share (EPS) at ₹5.70. The company has not recommended a dividend, opting to reinvest earnings to strengthen reserves to ₹6,576.77 Lakhs. Expansion of production facilities and securing an Environmental Clearance Certificate are also noted.

Everest Organics Ltd announced the appointment of Mr. Srikanth Reddy Kolli and Mr. Subroto Banerjee as Additional Directors (Independent Category) for a five-year term, subject to member approval. The Board also approved the reconstitution of its Audit Committee, Nomination and Remuneration Committee, Stakeholders Relationship Committee, and Corporate Social Responsibility Committee. Key decisions included approving the Board's Report for FY25-26, the notice for the 33rd Annual General Meeting (AGM) scheduled for September 30, 2026, and setting the record date for the AGM. The company also approved the payment of sitting fees to Non-Executive Independent Directors for attending Board and Committee meetings.

Everest Organics Ltd held a Board of Directors meeting on August 14, 2026, approving the appointment of Mr. Srikanth Reddy Kolli and Mr. Subroto Banerjee as Additional Directors (Independent Category) for a five-year term, subject to requisite approvals. The company also reconstituted its Audit Committee, Nomination and Remuneration Committee, Stakeholders Relationship Committee, and Corporate Social Responsibility Committee. The Board approved the Board's Report for FY 2025-26 and the notice for the 33rd Annual General Meeting (AGM) scheduled for September 30, 2026. The register of members and share transfer books will be closed from September 26 to September 30, 2026, with September 25, 2026, set as the record date. Payment of sitting fees to Non-Executive Independent Directors for attending Board and Committee meetings was also approved.

Everest Organics Ltd announced the appointment of Mr. Srikanth Reddy Kolli and Mr. Subroto Banerjee as Additional Directors in the Independent Category, effective August 14, 2026, for a term of five years. The board also reconstituted key committees, including the Audit Committee, Nomination and Remuneration Committee, and Stakeholders Relationship Committee, with the newly appointed directors taking on significant roles. The company also approved the Board's Report for FY 2025-26 and the notice for the 33rd Annual General Meeting scheduled for September 30, 2026. The register of members and share transfer books will be closed from September 26 to September 30, 2026, with September 25, 2026, set as the record date.

Everest Organics Ltd announced the appointment of Mr. Subroto Banerjee as an Additional Director in the Independent Category, effective August 14, 2026. This appointment is for an initial term of five years. The company's Board of Directors also reconstituted various committees, including the Audit Committee, Nomination and Remuneration Committee, Stakeholders Relationship Committee, and Corporate Social Responsibility Committee, with Mr. Banerjee taking on key roles in some of these. The Board also approved the Board's Report for FY 2025-26 and the notice for the 33rd Annual General Meeting scheduled for September 30, 2026. The register of members and share transfer books will be closed from September 26 to September 30, 2026, with September 25, 2026, set as the record date.

Everest Organics Ltd announced the appointment of Mr. Srikanth Reddy Kolli and Mr. Subroto Banerjee as Additional Directors (Independent Category) for a five-year term. The Board of Directors also reconstituted key committees, including the Audit Committee, Nomination and Remuneration Committee, Stakeholders Relationship Committee, and Corporate Social Responsibility Committee. The company approved its Board's Report for FY 2025-26 and the notice for its 33rd Annual General Meeting (AGM) scheduled for September 30, 2026. The Register of Members and Share Transfer Books will be closed from September 26 to September 30, 2026, with September 25, 2026, set as the record date. Remote e-voting will be open from September 27 to September 29, 2026.

Everest Organics Ltd announced the appointment of Mr. Srikanth Reddy Kolli and Mr. Subroto Banerjee as Additional Directors (Independent Category) for a term of five years, effective August 14, 2026. The company's Board of Directors also approved the re-constitution of its Audit Committee, Nomination and Remuneration Committee, Stakeholders Relationship Committee, and Corporate Social Responsibility Committee. Additionally, the Board approved the Board's Report for FY 2025-26 and the Notice for the 33rd Annual General Meeting (AGM) scheduled for September 30, 2026. The Register of Members and Share Transfer Books will be closed from September 26 to September 30, 2026, with September 25, 2026, fixed as the record date for the AGM.

Everest Organics Ltd announced its Un-audited Standalone Financial Results for the quarter ended June 30, 2026. The Board of Directors approved these results after a meeting that included a reconvened session following an Audit Committee meeting. The company operates in a single business segment: Active Pharmaceutical Ingredients (API) and their Intermediates. The results were reviewed by Statutory Auditors P.S.N. Ravishanker & Associates.

Everest Organics Ltd has announced that its Board of Directors will convene on August 14, 2026, to consider and approve the Un-audited Financial Results for the quarter ended June 30, 2026. The meeting will also review the Limited Review Report from statutory auditors, approve the Board's Report for FY 2025-26, and finalize arrangements for the 33rd Annual General Meeting, including setting its date, time, venue, and appointing a scrutinizer. The trading window remains closed until 48 hours after the results declaration.